Evidence map›Paper›PMID 42110765›Full record

ArticleACS omega2026

Rapid Detection of Amyloid β1-42 via PAMAM G4 Supported Molecularly Imprinted Sensor.

Hilmiye Deniz Ertuğrul Uygun, Münire Nalan Demir

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hilmiye Deniz Ertuğrul UygunDokuz Eylül University, Center for Fabrication and Application of Electronic Materials, Izmir 35390, Turkey.ORCID https://orcid.org/0000-0003-1631-527X
Münire Nalan DemirDokuz Eylül University, Faculty of Science, Department of Chemistry, Izmir 35390, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this research, a novel sensor system was prepared for the rapid and selective determination of Amyloid β1-42 (Aβ1-42), a key biomarker in the early recognition of Alzheimer's disease. A screen-printed gold electrode (AuE) was used as the base for a self-assembled monolayer (SAM)-based molecularly imprinted polymer (MIP). The electrode was modified by sequential incubation in 100 mM cysteamine, 5% glutaraldehyde, and PAMAM G4 dendrimer. Electropolymerization was performed using pyrrole-3-carboxylic acid and Aβ1-42. Desorption was achieved using 500 mM HCl to remove the template molecule, generating specific recognition sites. The sensor's performance was determined by electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV), with additional surface characterization via SEM, XPS, and FT-IR. The nonimprinted polymer (NIP) showed no response to Aβ1-42, confirming the selectivity of the MIP. Selectivity tests using Tau protein showed minimal interference. The quantification limit (LOQ) and the limit of detection (LOD) were found to be 0.42 and 0.14 ng/mL, respectively. In diagnostic applications, the proposed sensor shows promise as a quick, sensitive, and selective way to detect Aβ1-42.

Identifiers

PMID42110765
PMCPMC13150757

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.